IceCure Medical

IceCure Medical is a pioneering company in the field of cryoablation technology, specializing in minimally invasive treatments for cancer tumors. The company primarily serves oncologists and interventional radiologists, offering solutions for breast, kidney, lung, liver, and bone cancer. Operating in the healthcare and medical device market, IceCure Medical's business model revolves around the development and commercialization of its proprietary ProSense™ system. This system uses liquid nitrogen-based technology to freeze and destroy cancerous tissues, providing a painless and effective alternative to traditional surgical methods. IceCure Medical generates revenue through the sale of its cryoablation systems and related consumables, as well as through partnerships and clinical trials. The company aims to establish its technology as the gold standard in cancer treatment, focusing on improving patient outcomes, reducing recovery times, and lowering healthcare costs. Keywords: cryoablation, cancer treatment, ProSense system, minimally invasive, oncology, interventional radiology, liquid nitrogen, healthcare, medical devices, tumor therapy.